(68)Ga-Based Radiopharmaceuticals: Production and Application Relationship

The contribution of (68)Ga to the promotion and expansion of clinical research and routine positron emission tomography (PET) for earlier better diagnostics and individualized medicine is considerable. The potential applications of (68)Ga-comprising imaging agents include targeted, pre-targeted and...

Descripción completa

Detalles Bibliográficos
Autor principal: Velikyan, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332429/
https://www.ncbi.nlm.nih.gov/pubmed/26193247
http://dx.doi.org/10.3390/molecules200712913
_version_ 1783387348681097216
author Velikyan, Irina
author_facet Velikyan, Irina
author_sort Velikyan, Irina
collection PubMed
description The contribution of (68)Ga to the promotion and expansion of clinical research and routine positron emission tomography (PET) for earlier better diagnostics and individualized medicine is considerable. The potential applications of (68)Ga-comprising imaging agents include targeted, pre-targeted and non-targeted imaging. This review discusses the key aspects of the production of (68)Ga and (68)Ga-based radiopharmaceuticals in the light of the impact of regulatory requirements and endpoint pre-clinical and clinical applications.
format Online
Article
Text
id pubmed-6332429
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63324292019-01-24 (68)Ga-Based Radiopharmaceuticals: Production and Application Relationship Velikyan, Irina Molecules Review The contribution of (68)Ga to the promotion and expansion of clinical research and routine positron emission tomography (PET) for earlier better diagnostics and individualized medicine is considerable. The potential applications of (68)Ga-comprising imaging agents include targeted, pre-targeted and non-targeted imaging. This review discusses the key aspects of the production of (68)Ga and (68)Ga-based radiopharmaceuticals in the light of the impact of regulatory requirements and endpoint pre-clinical and clinical applications. MDPI 2015-07-16 /pmc/articles/PMC6332429/ /pubmed/26193247 http://dx.doi.org/10.3390/molecules200712913 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Velikyan, Irina
(68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
title (68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
title_full (68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
title_fullStr (68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
title_full_unstemmed (68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
title_short (68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
title_sort (68)ga-based radiopharmaceuticals: production and application relationship
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332429/
https://www.ncbi.nlm.nih.gov/pubmed/26193247
http://dx.doi.org/10.3390/molecules200712913
work_keys_str_mv AT velikyanirina 68gabasedradiopharmaceuticalsproductionandapplicationrelationship

Ejemplares similares